Divi's Laboratories Limited (DIVISLAB.NS)
INR 5640.0
(-1.98%)
INR 5640.0
(-1.98%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 25.43 Billion INR | -18.71% |
| 2022 | 27.13 Billion INR | -32.14% |
| 2021 | 39.97 Billion INR | 36.65% |
| 2020 | 29.23 Billion INR | 49.58% |
| 2019 | 20.12 Billion INR | -2.22% |
| 2018 | 20.26 Billion INR | 45.15% |
| 2017 | 13.76 Billion INR | -9.24% |
| 2016 | 15.2 Billion INR | 1.1% |
| 2015 | 15.12 Billion INR | 23.52% |
| 2014 | 12.1 Billion INR | 11.59% |
| 2013 | 10.84 Billion INR | 26.73% |
| 2012 | 8.59 Billion INR | 17.82% |
| 2011 | 7.45 Billion INR | 38.21% |
| 2010 | 5.26 Billion INR | 20.11% |
| 2009 | 4.39 Billion INR | -96.05% |
| 2008 | 4.99 Billion INR | 2591.11% |
| 2007 | 4.13 Billion INR | 71.03% |
| 2006 | 2.41 Billion INR | 100.48% |
| 2005 | 1.2 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | 5.65 Billion INR | -3.42% |
| 2023 FY | - INR | -18.71% |
| 2023 Q4 | 6.23 Billion INR | -14.77% |
| 2023 Q3 | 7.31 Billion INR | 25.17% |
| 2023 Q2 | 5.84 Billion INR | 3.36% |
| 2022 Q3 | 5.53 Billion INR | 5.97% |
| 2022 Q1 | 7.01 Billion INR | -25.02% |
| 2022 FY | - INR | -32.14% |
| 2022 Q2 | 5.22 Billion INR | -25.47% |
| 2022 Q4 | 5.85 Billion INR | 5.65% |
| 2021 Q2 | 11.13 Billion INR | 33.04% |
| 2021 Q4 | 9.35 Billion INR | -19.28% |
| 2021 Q3 | 11.58 Billion INR | 4.01% |
| 2021 Q1 | 8.37 Billion INR | -5.73% |
| 2021 FY | - INR | 36.65% |
| 2020 Q3 | 7.39 Billion INR | 4.05% |
| 2020 FY | - INR | 49.58% |
| 2020 Q4 | 8.88 Billion INR | 20.12% |
| 2020 Q2 | 7.1 Billion INR | -5.86% |
| 2020 Q1 | 7.54 Billion INR | 5.21% |
| 2019 Q1 | 5.37 Billion INR | 28.78% |
| 2019 Q3 | 4.65 Billion INR | -13.17% |
| 2019 Q4 | 7.17 Billion INR | 54.27% |
| 2019 FY | - INR | -2.22% |
| 2019 Q2 | 5.35 Billion INR | -0.38% |
| 2018 Q2 | 5.67 Billion INR | -5.75% |
| 2018 FY | - INR | 45.15% |
| 2018 Q4 | 4.17 Billion INR | -2.89% |
| 2018 Q3 | 4.29 Billion INR | -24.22% |
| 2018 Q1 | 6.01 Billion INR | 50.1% |
| 2017 FY | - INR | -9.24% |
| 2017 Q4 | 4.01 Billion INR | 0.0% |
| 2016 FY | - INR | 1.1% |
| 2015 FY | - INR | 23.52% |
| 2014 Q3 | 3.16 Billion INR | 0.0% |
| 2014 FY | - INR | 11.59% |
| 2013 FY | - INR | 26.73% |
| 2013 Q3 | 2.74 Billion INR | 0.0% |
| 2012 Q3 | 2.53 Billion INR | 0.0% |
| 2012 FY | - INR | 17.82% |
| 2011 FY | - INR | 38.21% |
| 2010 FY | - INR | 20.11% |
| 2009 FY | - INR | -96.05% |
| 2008 FY | - INR | 2591.11% |
| 2007 FY | - INR | 71.03% |
| 2006 FY | - INR | 100.48% |
| 2005 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hester Biosciences Limited | 539.47 Million INR | -4613.886% |
| Albert David Limited | 1.04 Billion INR | -2332.508% |
| Alembic Limited | 1.11 Billion INR | -2177.98% |
| Alkem Laboratories Limited | 24.19 Billion INR | -5.104% |
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | -164.436% |
| Bafna Pharmaceuticals Limited | 114.58 Million INR | -22093.519% |
| Bajaj HealthCare Limited | 406.23 Million INR | -6159.877% |
| FDC Limited | 3.38 Billion INR | -651.173% |
| Glenmark Life Sciences Limited | 6.86 Billion INR | -270.544% |
| Gufic Biosciences Limited | 1.48 Billion INR | -1617.679% |
| Hikal Limited | 2.69 Billion INR | -844.57% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | -270.611% |
| Ind-Swift Limited | 1.06 Billion INR | -2287.645% |
| Innova Captab Limited | 1.66 Billion INR | -1424.297% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | -7761.869% |
| Jubilant Pharmova Limited | 8 Billion INR | -217.637% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | -8747.525% |
| Laurus Labs Limited | 8 Billion INR | -217.637% |
| Lincoln Pharmaceuticals Limited | 1.34 Billion INR | -1793.068% |
| Lupin Limited | 36.96 Billion INR | 31.213% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | -14435.914% |
| Medico Remedies Limited | 129.09 Million INR | -19598.824% |
| Morepen Laboratories Limited | 1.72 Billion INR | -1373.388% |
| Nectar Lifesciences Limited | 1.53 Billion INR | -1556.041% |
| Orchid Pharma Limited | 1.41 Billion INR | -1691.881% |
| Procter & Gamble Health Limited | 3.07 Billion INR | -727.153% |
| RPG Life Sciences Limited | 1.28 Billion INR | -1884.393% |
| Solara Active Pharma Sciences Limited | -2.82 Billion INR | 1001.166% |
| Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 81.621% |
| Suven Pharmaceuticals Limited | 4.67 Billion INR | -443.703% |
| Themis Medicare Limited | 562.6 Million INR | -4420.029% |
| Unichem Laboratories Limited | 742.35 Million INR | -3325.58% |
| Vaishali Pharma Limited | 31.71 Million INR | -80092.993% |
| Venus Remedies Limited | 711.8 Million INR | -3472.628% |
| Wanbury Limited | 985.49 Million INR | -2480.442% |
| Windlas Biotech Limited | 781.72 Million INR | -3153.083% |
| ZIM Laboratories Limited | 462.09 Million INR | -5403.174% |
| Ipca Laboratories Limited | 13.29 Billion INR | -91.21% |
| Aarti Drugs Limited | 3.24 Billion INR | -682.792% |
| Aarti Pharmalabs Limited | 3.9 Billion INR | -550.48% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.99 Million INR | -195575.592% |
| Brooks Laboratories Limited | 41.72 Million INR | -60842.293% |
| Eris Lifesciences Limited | 6.98 Billion INR | -263.99% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | -875.6% |
| Sigachi Industries Limited | 883.39 Million INR | -2778.657% |
| Sakar Healthcare Limited | 393.26 Million INR | -6366.328% |
| Aurobindo Pharma Limited | 61.78 Billion INR | 58.843% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | -979.005% |
| Mankind Pharma Limited | 28.09 Billion INR | 9.485% |
| Sequent Scientific Limited | 549.8 Million INR | -4525.318% |
| Neuland Laboratories Limited | 4.74 Billion INR | -435.573% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | -172.421% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | -124.177% |
| Zydus Lifesciences Limited | 56.22 Billion INR | 54.769% |
| Amrutanjan Health Care Limited | 681.59 Million INR | -3630.949% |
| Wockhardt Limited | 1.08 Billion INR | -2254.63% |
| Bal Pharma Limited | 345.59 Million INR | -7258.388% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 71.192% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | -1619.37% |
| Par Drugs and Chemicals Limited | 228.17 Million INR | -11045.003% |
| Caplin Point Laboratories Limited | 6.18 Billion INR | -311.236% |
| Shilpa Medicare Limited | 2.58 Billion INR | -882.619% |
| Valiant Laboratories Limited | 12.73 Million INR | -199523.204% |
| Ajanta Pharma Limited | 12.56 Billion INR | -102.381% |
| Aarey Drugs & Pharmaceuticals Limited | 45.16 Million INR | -56204.661% |
| Granules India Limited | 8.6 Billion INR | -195.566% |
| Medicamen Biotech Limited | 245.66 Million INR | -10251.706% |
| Syncom Formulations (India) Limited | 430.27 Million INR | -5810.16% |
| Piramal Enterprises Limited | -3.86 Billion INR | 758.621% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | 27.363% |
| NATCO Pharma Limited | 18.79 Billion INR | -35.302% |
| Suven Life Sciences Limited | -992.78 Million INR | 2661.494% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | 30839.662% |
| Strides Pharma Science Limited | 3.76 Billion INR | -575.489% |
| Indoco Remedies Limited | 2.64 Billion INR | -860.691% |
| Alpa Laboratories Limited | 229.96 Million INR | -10958.397% |
| Lasa Supergenerics Limited | -65.08 Million INR | 39174.985% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 781.501% |